A cohort of Axenfeld-Rieger Syndrome (ARS) patients also exhibited cerebral small vessel disease (CSVD) as a result of abnormal FOXC1 function, thus implicating FOXC1 dysfunction in the progression of CSVD and stroke11. This evidence concerns the gene FOXC1 and cerebral small vessel disease.